|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 1/22 | |
| A61K 47/68 |
| (11) | Patento numeris | 3394082 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16823047.2 |
| Europos patento paraiškos padavimo data | 2016-12-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2016/057417 |
| Data | 2016-12-07 |
| (87) | Numeris | WO 2017/109619 |
| Data | 2017-06-29 |
| (30) | Numeris | Data | Šalis |
| 201562270174 P | 2015-12-21 | US |
| (72) |
NADKARNI, Durgesh V., US
BORGMEYER, Jeffry R., US
MENG, He, US
JIANG, Qingping, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | PURIFICATION OF ANTIBODY DRUG CONJUGATES USING A SODIUM PHOSPHATE GRADIENT |
| PURIFICATION OF ANTIBODY DRUG CONJUGATES USING A SODIUM PHOSPHATE GRADIENT |